![Antibiotics | Free Full-Text | Comparison between Ceftriaxone and Sulbactam- Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis Antibiotics | Free Full-Text | Comparison between Ceftriaxone and Sulbactam- Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis](https://www.mdpi.com/antibiotics/antibiotics-11-01291/article_deploy/html/images/antibiotics-11-01291-g001.png)
Antibiotics | Free Full-Text | Comparison between Ceftriaxone and Sulbactam- Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
![PDF) Ampicillin/Sulbactam in Combination: A Review of its Use in the Treatment of Severe Bacterial Infections PDF) Ampicillin/Sulbactam in Combination: A Review of its Use in the Treatment of Severe Bacterial Infections](https://www.researchgate.net/profile/Azucena-Rodriguez-Guardado/publication/269659432/figure/tbl1/AS:671526445666307@1537115789143/Principal-studies-about-Ampicillin-Sulbactam-in-intra-abdominal-infections_Q320.jpg)
PDF) Ampicillin/Sulbactam in Combination: A Review of its Use in the Treatment of Severe Bacterial Infections
![AMPICILLIN CAPSULES, USP 250 mg and 500 mg AMPICILLIN FOR ORAL SUSPENSION, USP 125 mg/5 mL and 250 mg/5 mL Rx Only AMPICILLIN CAPSULES, USP 250 mg and 500 mg AMPICILLIN FOR ORAL SUSPENSION, USP 125 mg/5 mL and 250 mg/5 mL Rx Only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=LABEL_AMPICILLIN+CAPS+500MG_BPI%2810544-122-28%29_DAVA%2867253-181-50%29_REV0.jpg&id=156504)
AMPICILLIN CAPSULES, USP 250 mg and 500 mg AMPICILLIN FOR ORAL SUSPENSION, USP 125 mg/5 mL and 250 mg/5 mL Rx Only
![PDF] Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis. | Semantic Scholar PDF] Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cdec125b941d33ceee630870e65008c95e5b0ae4/4-Table2-1.png)